Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-293599
Filing Date
2023-12-13
Accepted
2023-12-12 19:05:58
Documents
1
Effectiveness Date
2023-12-13

Document Format Files

Seq Description Document Type Size
1 S-8 POS d543139ds8pos.htm S-8 POS 51978
  Complete submission text file 0001193125-23-293599.txt   52984
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-275990 | Film No.: 231482526
SIC: 2834 Pharmaceutical Preparations